Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy

RE Eilers Jr, M Gandhi, JD Patel… - Journal of the …, 2010 - academic.oup.com
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

[PDF][PDF] Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

RE Eilers Jr, M Gandhi, JD Patel, MF Mulcahy… - J Natl Cancer Inst, 2010 - Citeseer
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

[PDF][PDF] Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

RE Eilers Jr, M Gandhi, JD Patel, MF Mulcahy… - J Natl Cancer …, 2010 - researchgate.net
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy

RE Eilers Jr, M Gandhi, JD Patel… - Journal of the …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy.

RE Eilers Jr, M Gandhi, JD Patel… - Journal of the …, 2009 - europepmc.org
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

[PDF][PDF] Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

RE Eilers Jr, M Gandhi, JD Patel, MF Mulcahy… - J Natl Cancer …, 2010 - scholar.archive.org
Background Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy.

REJ Eilers, M Gandhi, JD Patel, MF Mulcahy, M Agulnik… - 2010 - cabidigitallibrary.org
Background: Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

[引用][C] Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy

RE Eilers, M Gandhi, JD Patel, MF Mulcahy… - JNCI Journal of the …, 2009 - cir.nii.ac.jp
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor
Inhibitor Therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy

RE Eilers, M Gandhi, JD Patel… - Journal of the …, 2010 - scholars.northwestern.edu
Background: Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …

Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy.

RE Eilers Jr, M Gandhi, JD Patel… - JNCI: Journal of the …, 2010 - search.ebscohost.com
Background: Patients treated with epidermal growth factor receptor inhibitors (EGFRIs)
frequently experience dermatologic toxic effects. Whereas the impact of these effects on …